Bryn Mawr Capital Management LLC Has $440,000 Holdings in The Clorox Company (NYSE:CLX)

Bryn Mawr Capital Management LLC grew its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 7.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,711 shares of the company’s stock after acquiring an additional 185 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Clorox were worth $440,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC increased its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter worth approximately $32,000. Finally, Catalyst Capital Advisors LLC bought a new position in shares of Clorox during the third quarter worth approximately $54,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CLX. JPMorgan Chase & Co. raised their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $158.21.

Check Out Our Latest Stock Report on Clorox

Clorox Price Performance

CLX stock opened at $157.41 on Friday. The company has a 50 day simple moving average of $157.87 and a 200 day simple moving average of $159.63. The stock has a market cap of $19.39 billion, a price-to-earnings ratio of 43.01, a P/E/G ratio of 2.58 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the business posted $2.16 earnings per share. Research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.